Fact CheckerSign in

NCT07521865Completed

Remote Technologies in Early Stages of Alzheimer's Disease

Remote Technologies in Early Stages of Alzheimer's Disease: Feasibility, Usability, and Acceptance of an App-based Cognitive Training

Source: ClinicalTrials.gov · Last updated 26 Jun 2026

Brief summary (registry, in English)

The investigators are adapting a tablet-based cognitive training program for Alzheimer's disease (AD) by focusing on specific cognitive components. It is aimed to demonstrate the feasibility, acceptability and usability of remote cognitive training in older adults with Mild Cognitive Impairment (MCI) and AD dementia. The study involves 36 participants in three groups, with a two-week intervention and focus groups for refinement.

Status (registry)
Completed
Study type
Observational
Enrollment
52 (actual)
First submitted
17 Nov 2025
Start date
Jun 2023
Primary completion date
Apr 2026
Lead sponsor
University of Bern
NCT number
NCT07521865

What you commit to

  • Study type: Observational
  • Participants enrolled: 52
  • From Jun 2023 to the primary completion date, Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe neurological or psychiatric conditions (of note: patients with mild depressive symptoms not fulfilling the criteria for major depressive disorder will be recruited into the sample to better represent clinical reality)

Other

  • Substance abuse

Criteria the registry did not label

  • Participants and study partners fulfilling all the following inclusion criteria are eligible for the study:
  • Informed Consent as documented by signature
    • Study partners:
  • Native or fluent German speaker
    • Participants:
  • Are able to give their consent to participate in the study
  • Age between 70 and 95 years
  • Native or fluent German speaker
  • Normal or corrected to normal vision and hearing
  • Ability to visit the study location repeatedly
  • MoCA score \> 11

Age in the registry: 70 years to 95 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital of Old Age Psychiatry and Psychotherapy Bern
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.